US regulator rejects Fortress Biotech’s experimental pediatric medicineÂ
The US regulator has declined to approve an experimental pediatric drug of Fortress Biotech Inc., an American biotechnology company, due to certain production.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
The US regulator has declined to approve an experimental pediatric drug of Fortress Biotech Inc., an American biotechnology company, due to certain production.
At least 12 people have died, and 740 new patients were admitted to hospitals as dengue cases in the South Asian nation of.
HQ Team June 10, 2025:Underreporting of brain tumour cases and non-availability of neuroimaging facilities in India may be the cause of the low.
HQ Team June 3, 2025: The number of active Covid-19 cases in India approached the 4,000-mark, with 161 people infected with the disease.
HQ Team May 16, 2025: Dengue fever has become a serious and growing health threat in India, especially between July and mid-November. Recent.
HQ Team May 7, 2025: It was World Asthma Day on May 6, and let us see how India has fared in the.
HQ Team April 18, 2025: Generic drugs made in India, which account for 93% of such medicines made from emerging countries, are linked.
HQ Team March 11, 2025: A recent World Air Quality Report 2024 by Swiss air quality technology company IQAir, has highlighted that 13.
US-based private equity and advisory investment firm KKR & Co. Inc. will pay CVC Capital Partners $400 million to acquire a majority stake.
The US, the world’s second-largest greenhouse gas emitter in the world, will withdraw from a global pact to limit global warming.
We use cookies to improve your experience on our site. By using our site, you consent to cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
Statistics cookies collect information anonymously. This information helps us understand how visitors use our website.
Google Analytics is a powerful tool that tracks and analyzes website traffic for informed marketing decisions.
Service URL: policies.google.com